产品

您的位置:首页 > 食品资讯 > 外讯导读 > 欧盟发布2018/2019人畜共患病细菌的抗菌素耐药性报告

欧盟发布2018/2019人畜共患病细菌的抗菌素耐药性报告

来源:好招商食品网 外讯导读   |  2024-04-25
   好招商食品网讯  2021年4月12日,欧盟食品安全局(EFSA)发布2018/2019人畜共患病细菌抗菌素耐药性(antimicrobial resistance ,AMR)的总结报告。
 
  部分原文报道如下:
 
  Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by the EFSA and the ECDC and reported in a yearly EU Summary Report. The annual monitoring of AMR in animals and food within the EU is targeted at seleced animal species corresponding to the reporting year. The 2018 monitoring specifically focussed on poultry and their derived carcases/meat, while the monitoring performed in 2019 specifically focused on pigs and calves under 1 year of age, as well as their derived carcases/meat. Monitoring and reporting of AMR in 2018/2019 included data regarding Salmonella, Campylobacter and indicator Escherichia coli isolates, as well as data obtained from the specific monitoring of presumptive ESBL‐/AmpC‐/carbapenemase‐producing E. coli isolates. Additionally, some MSs reported voluntary data on the occurrence of meticillin‐resistant Staphylococcus aureus in animals and food, with some countries also providing data on antimicrobial susceptibility. This report provides an overview of the main findings of the 2018/2019 harmonised AMR monitoring in the main food‐producing animal populations monitored, in related carcase/meat samples and in humans. wher available, data monitoring obtained from pigs, calves, broilers, laying hens and turkeys, as well as from carcase/meat samples and humans were combined and compared at the EU level, with particular emphasis on multidrug resistance, complete susceptibility and combined resistance patterns to critically important antimicrobials, as well as Salmonella and E. coli isolates possessing ESBL‐/AmpC‐/carbapenemase phenotypes. The outcome indicators for AMR in food‐producing animals such as complete susceptibility to the harmonised panel of antimicrobials in E. coli and the prevalence of ESBL‐/AmpC‐producing E. coli have been also specifically analysed over the period 2015–2019.
 
  更多详情参见:https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2021.6490
 

TAGS:抗菌素 安全局 食品安全 细菌 欧盟
免责声明:本站部分文章转载自网络,图文仅供行业学习交流使用,不做任何商业用途。文章仅代表原作者个人观点,其原创性及文章内容中图文的真实性、完整性等未经本站核实,仅供读者参考。
上一篇: 欧盟拟制定磷酸钾在蓝莓中的进口限量
下一篇: 欧盟评估银杏叶提取物作为猫和狗饲料添加剂的安全性和有效性